A drug-eluting coronary stent system designed to treat coronary artery disease by delivering sirolimus to prevent restenosis. The stent is placed via percutaneous coronary intervention to restore blood flow in narrowed arteries.
Manufactured by
Relisys Medical Devices Ltd
Hyderabad, India
Relisys Medical Devices Limited is one of the world s largest manufacturer of cardiovascular medical devices including Coronary Stent Systems – both Bare Metal Stent Systems Drug Eluting Stent Systems, PTCA Balloon Catheters, Angiographic Diagnostic Catheters, Guiding Catheters and Transcatheter Heart Valves. We constantly innovate and upgrade our portfolio to offer solutions to treat life-threatening heart diseases. Backed by strong R D, we constantly work on process product innovation thereby offering better solutions to the patients at affordable prices.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Shanghai Easy-Flow Medical Tech Co., Ltd
China · 5 relevant products
Lepu Medical (Europe) Inc. Coöperatief U.A
Netherlands · 3 relevant products
Kossel Medtech (Suzhou) Co., Ltd.
China · 3 relevant products
63 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →12 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 111 closest product alternatives
Shanghai Easy-Flow Medical Tech Co., Ltd · China
Peripheral drug-eluting stent for arterial disease treatment, delivering sirolimus to prevent restenosis in peripheral vasculature.
Lepu Medical (Europe) Inc. Coöperatief U.A · Netherlands
Bioabsorbable sirolimus-eluting stent system designed for percutaneous coronary intervention (PCI) in coronary artery disease. The stent delivers sirolimus to inhibit neointimal hyperplasia while the polymer scaffold gradually resorbs, restoring vasomotor function. Indicated for patients with de novo coronary lesions requiring revascularization.
Kossel Medtech (Suzhou) Co., Ltd. · China
MiStent® is a sirolimus-eluting coronary stent with absorbable polymer coating designed for percutaneous coronary intervention. The cobalt chromium alloy structure provides sustained radial support and fatigue resistance for treating coronary artery stenosis. The drug-eluting mechanism reduces neointimal proliferation while the absorbable polymer eliminates chronic inflammatory response after healing.
108 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products